
### [Orphanet:738](http://www.orpha.net/ORDO/Orphanet_738)
**Label:** Porphyria

**Subclasses:** [Orphanet:79278](http://www.orpha.net/ORDO/Orphanet_79278) (Autosomal erythropoietic protoporphyria), [Orphanet:79277](http://www.orpha.net/ORDO/Orphanet_79277) (Congenital erythropoietic porphyria), [Orphanet:443197](http://www.orpha.net/ORDO/Orphanet_443197) (X-linked erythropoietic protoporphyria), 

**Corr. equiv. classes:** [OMIM:263700](http://purl.obolibrary.org/obo/OMIM_263700), [OMIM:177000](http://purl.obolibrary.org/obo/OMIM_177000), [OMIM:300752](http://purl.obolibrary.org/obo/OMIM_300752), [Orphanet:443197](http://www.orpha.net/ORDO/Orphanet_443197), [Orphanet:79277](http://www.orpha.net/ORDO/Orphanet_79277), [Orphanet:79278](http://www.orpha.net/ORDO/Orphanet_79278), 

**Class expressions from DL-Learner:**

- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) 66.67%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) 66.67%
- [HP:0000969](http://purl.obolibrary.org/obo/HP_0000969) (Edema) and [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) 66.67%
- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 66.67%
- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 66.67%
- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 66.67%
- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) 66.67%
- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) 66.67%
- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 66.67%
- [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) 66.67%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 66.67%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 66.67%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 66.67%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) 66.67%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) 66.67%


